Mehmet Özalevli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mehmet Özalevli has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Burak Arslan
Department of Urology, University of Health Sciences Gaziosmanpaşa Training and Research Hospital, Istanbul, Turkey
4 shared publications - Mucahit Gelmis
Gaziosmanpaşa Eğitim ve Araştırma Hastanesi
4 shared publications - Ali Ayten
Department of Urology Gaziosmanpasa Training and Research Hospital University of Health Sciences İstanbul Türkiye
3 shared publications - Andreia Bilé-Silva
Department of Targeted Intervention University College London London UK
2 shared publications - Serkan Gönültaş
Bağcılar Eğitim ve Araştırma Hastanesi
2 shared publications - Sina Kardas
Department of Urology, Gaziosmanpasa Training and Research Hospital, Karayolları Mah Osmanbey Cad 621. Sok 34255, Gaziosmanpasa, Istanbul, Turkey
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Wiley in BJU International
Oncological and continence outcomes after nerve‐sparing robot‐assisted radical prostatectomy in selected STAMPEDE‐defined high‐risk prostate cancer
Objectives: To examine the association between the nerve‐sparing (NS) technique applied during radical prostatectomy (RP) and early oncological and continence outcomes in patients with Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE)‐defined high‐risk prostate cancer (PCa) undergoing robot‐assisted RP (RARP) within a structured patient‐specific surgical planning (PSSP) pathway. Patients and Methods: A retrospective single‐centre cohort study of 1385 patients who underwent primary RARP between 2021 and 2022 was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. Patients were stratified into three groups according to the number of STAMPEDE‐defined high‐risk factors: none, one, and two or more. Outcomes were compared across these cohorts and between NS‐ and non‐NS (nNS)‐ RARP, within each risk stratum. Results: Overall, NS‐RARP was performed in 75.4% of patients (1044/1385). In the STAMPEDE‐defined high‐risk cohort (two or more high‐risk criteria) 57.3% (150/262) of patients underwent some sort of NS. Among those with at least two STAMPEDE‐defined risk factors, oncological outcomes were similar between NS and nNS surgery (positive surgical margin rate 21.3% vs 23.2%, P = 0.72; 12‐month biochemical recurrence rate 6.7% vs 5.4%, P = 0.9), and urinary continence rates at 3 and 12 months were also similar ( P = 0.2 and P = 0.5, respectively). However, high‐risk patients undergoing NS‐RARP used significantly fewer pads at 12 months ( P = 0.03). Conclusion: In a contemporary RARP cohort within a PSSP pathway, NS was feasible in over half of high‐risk patients and was not associated with worse short‐term oncological outcomes. Although pad‐free continence rates were similar between NS and nNS groups, patients undergoing NS‐RARP used significantly fewer pads at 12 months, suggesting a potential functional benefit that warrants further prospective evaluation of NS strategies in selected cases.
- 30 September 2026
- Published by Wiley in BJU International
Open AccessOncological and continence outcomes after nerve‐sparing robot‐assisted radical prostatectomy in selected STAMPEDE‐defined high‐risk prostate cancer
Objectives: To examine the association between the nerve‐sparing (NS) technique applied during radical prostatectomy (RP) and early oncological and continence outcomes in patients with Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE)‐defined high‐risk prostate cancer (PCa) undergoing robot‐assisted RP (RARP) within a structured patient‐specific surgical planning (PSSP) pathway. Patients and Methods: A retrospective single‐centre cohort study of 1385 patients who underwent primary RARP between 2021 and 2022 was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement. Patients were stratified into three groups according to the number of STAMPEDE‐defined high‐risk factors: none, one, and two or more. Outcomes were compared across these cohorts and between NS‐ and non‐NS (nNS)‐ RARP, within each risk stratum. Results: Overall, NS‐RARP was performed in 75.4% of patients (1044/1385). In the STAMPEDE‐defined high‐risk cohort (two or more high‐risk criteria) 57.3% (150/262) of patients underwent some sort of NS. Among those with at least two STAMPEDE‐defined risk factors, oncological outcomes were similar between NS and nNS surgery (positive surgical margin rate 21.3% vs 23.2%, P = 0.72; 12‐month biochemical recurrence rate 6.7% vs 5.4%, P = 0.9), and urinary continence rates at 3 and 12 months were also similar ( P = 0.2 and P = 0.5, respectively). However, high‐risk patients undergoing NS‐RARP used significantly fewer pads at 12 months ( P = 0.03). Conclusion: In a contemporary RARP cohort within a PSSP pathway, NS was feasible in over half of high‐risk patients and was not associated with worse short‐term oncological outcomes. Although pad‐free continence rates were similar between NS and nNS groups, patients undergoing NS‐RARP used significantly fewer pads at 12 months, suggesting a potential functional benefit that warrants further prospective evaluation of NS strategies in selected cases.
- 29 May 2026
- Published by Endouroloji Dernegi in Endouroloji Bulteni
- Vol. 18 (2) , 90-99
Impact of pT1a–pT1b Substaging on Recurrence and Progression in High-Grade T1 Bladder Cancer
Objective: To evaluate the prognostic impact of pT1a–pT1b substaging on recurrence and progression in patients with high-grade T1 bladder cancer and to determine whether substaging serves as an independent predictor when assessed alongside established clinical and pathological risk factors.Materials and Methods: This retrospective, single-center cohort study included patients diagnosed with high-grade pT1 urothelial carcinoma who underwent TURBT between January 2017 and March 2025. Cases with ≥pT2 disease, other malignancies, BCG contraindications, treatment non-compliance, incomplete follow-up, or trigonal tumors with unreliable muscularis mucosa assessment were excluded. Demographic, clinical, pathological, and follow-up data were extracted from institutional records. Recurrence and progression were defined according to standard criteria. Substaging was performed by experienced uropathologists. Survival outcomes were analyzed using the Kaplan–Meier method, and independent predictors were identified by multivariate Cox regression.Results: Of 152 patients, 110 (72.4%) were classified as pT1a and 42 (27.6%) as pT1b. CIS and tumor size ≥3 cm were significantly more frequent in pT1b cases. In multivariate analysis, CIS and tumor size ≥3 cm were independent predictors of both recurrence and progression. Although pT1b substaging was associated with worse recurrence-free survival on Kaplan–Meier analysis, it was not an independent predictor of recurrence in the Cox model; however, it independently predicted progression (HR=3.38). Kaplan–Meier analyses also demonstrated significantly worse progression-free survival in the pT1b group.Conclusion: pT1 substaging, particularly the identification of pT1b disease, provides meaningful prognostic information for progression in high-grade T1 bladder cancer. Integrating substaging with key pathological factors such as CIS and tumor size may improve individualized risk stratification and support early risk-adapted treatment decisions.
- 29 May 2026
- Published by Endouroloji Dernegi in Endouroloji Bulteni
- Vol. 18 (2) , 90-99
Impact of pT1a–pT1b Substaging on Recurrence and Progression in High-Grade T1 Bladder Cancer
Objective: To evaluate the prognostic impact of pT1a–pT1b substaging on recurrence and progression in patients with high-grade T1 bladder cancer and to determine whether substaging serves as an independent predictor when assessed alongside established clinical and pathological risk factors.Materials and Methods: This retrospective, single-center cohort study included patients diagnosed with high-grade pT1 urothelial carcinoma who underwent TURBT between January 2017 and March 2025. Cases with ≥pT2 disease, other malignancies, BCG contraindications, treatment non-compliance, incomplete follow-up, or trigonal tumors with unreliable muscularis mucosa assessment were excluded. Demographic, clinical, pathological, and follow-up data were extracted from institutional records. Recurrence and progression were defined according to standard criteria. Substaging was performed by experienced uropathologists. Survival outcomes were analyzed using the Kaplan–Meier method, and independent predictors were identified by multivariate Cox regression.Results: Of 152 patients, 110 (72.4%) were classified as pT1a and 42 (27.6%) as pT1b. CIS and tumor size ≥3 cm were significantly more frequent in pT1b cases. In multivariate analysis, CIS and tumor size ≥3 cm were independent predictors of both recurrence and progression. Although pT1b substaging was associated with worse recurrence-free survival on Kaplan–Meier analysis, it was not an independent predictor of recurrence in the Cox model; however, it independently predicted progression (HR=3.38). Kaplan–Meier analyses also demonstrated significantly worse progression-free survival in the pT1b group.Conclusion: pT1 substaging, particularly the identification of pT1b disease, provides meaningful prognostic information for progression in high-grade T1 bladder cancer. Integrating substaging with key pathological factors such as CIS and tumor size may improve individualized risk stratification and support early risk-adapted treatment decisions.
- Open Access
- 17 April 2026
- Published by MDPI AG in Precision Oncology
- Vol. 1 (2) , 8
Predictive Value of Pre-Biopsy MRI Findings for Detection of Seminal Vesicle Invasion in Prostate Cancer—A Systematic Review and Meta-Analysis
Background/Objectives: Prostate cancer (PCa) incidence is rising, with radical prostatectomy (RP) as the main curative surgery for localised cases, which includes removing seminal vesicles (SV). SV invasion (SVI) predicts poor oncological outcomes, making accurate preoperative staging to identify SVI crucial for surgical planning. This ensures oncological safety by enabling wide excision when needed, while preserving tissue to maintain function. This review synthesises current evidence on pre-biopsy MRI findings and/or clinicopathological parameters to diagnose SVI in PCa. Methods: A literature search (2005–2025) using OVID for studies assessing pre-biopsy MRI findings, with a priori eligibility for clinicopathological or combined MRI–clinicopathological models (index tests), for detecting SVI (outcome) compared to RP histopathology (standard reference) in patients with primary localised PCa (patients). This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Risk of bias was evaluated with QUADAS-2, and pooled diagnostic accuracy metrics and study heterogeneity were analysed. Results: Five studies qualified, while three used binary mpMRI classification and were quantitatively analysed. No eligible studies assessed clinicopathological predictors or combined MRI–clinicopathological models; all included studies evaluated pre-biopsy MRI findings only, and none included high-dimensional radiomics. The pooled sensitivity was 0.66 (95% CI: 0.52–0.78), specificity 0.94 (0.89–0.97), positive predictive value (PPV) 0.76 (0.60–0.87), negative predictive value (NPV) 0.92 (0.85–0.94), and diagnostic odds ratio 30.13 (12.36–73.47), with moderate heterogeneity. All included studies were retrospective cohorts with considerable risk of bias. Conclusions: In the small number of heterogeneous, single-centre retrospective studies available, pre-biopsy MRI findings show high specificity and NPV for preoperative detection of SVI but only moderate sensitivity, which limits its reliability as a standalone tool. The pooled diagnostic accuracy estimates should be interpreted as exploratory. These findings should therefore be interpreted cautiously. Future studies must integrate MRI with clinicopathological data, addressing this key evidence gap before firm conclusions can be drawn or clinical practice changed.
- 17 April 2026
- Published by MDPI AG in Precision Oncology
- Vol. 1 (2) , 8
Open AccessPredictive Value of Pre-Biopsy MRI Findings for Detection of Seminal Vesicle Invasion in Prostate Cancer—A Systematic Review and Meta-Analysis
Background/Objectives: Prostate cancer (PCa) incidence is rising, with radical prostatectomy (RP) as the main curative surgery for localised cases, which includes removing seminal vesicles (SV). SV invasion (SVI) predicts poor oncological outcomes, making accurate preoperative staging to identify SVI crucial for surgical planning. This ensures oncological safety by enabling wide excision when needed, while preserving tissue to maintain function. This review synthesises current evidence on pre-biopsy MRI findings and/or clinicopathological parameters to diagnose SVI in PCa. Methods: A literature search (2005–2025) using OVID for studies assessing pre-biopsy MRI findings, with a priori eligibility for clinicopathological or combined MRI–clinicopathological models (index tests), for detecting SVI (outcome) compared to RP histopathology (standard reference) in patients with primary localised PCa (patients). This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Risk of bias was evaluated with QUADAS-2, and pooled diagnostic accuracy metrics and study heterogeneity were analysed. Results: Five studies qualified, while three used binary mpMRI classification and were quantitatively analysed. No eligible studies assessed clinicopathological predictors or combined MRI–clinicopathological models; all included studies evaluated pre-biopsy MRI findings only, and none included high-dimensional radiomics. The pooled sensitivity was 0.66 (95% CI: 0.52–0.78), specificity 0.94 (0.89–0.97), positive predictive value (PPV) 0.76 (0.60–0.87), negative predictive value (NPV) 0.92 (0.85–0.94), and diagnostic odds ratio 30.13 (12.36–73.47), with moderate heterogeneity. All included studies were retrospective cohorts with considerable risk of bias. Conclusions: In the small number of heterogeneous, single-centre retrospective studies available, pre-biopsy MRI findings show high specificity and NPV for preoperative detection of SVI but only moderate sensitivity, which limits its reliability as a standalone tool. The pooled diagnostic accuracy estimates should be interpreted as exploratory. These findings should therefore be interpreted cautiously. Future studies must integrate MRI with clinicopathological data, addressing this key evidence gap before firm conclusions can be drawn or clinical practice changed.
- 1 January 2026
- Published by Turk Androloji Dernegi in Androloji Bülteni
Pleomorphic fibroma of the penis: A rare case report
GİRİŞ: Pleomorfik fibrom, ilk kez 1989 yılında Kamino ve ark. tarafından tanımlanan, nadir görülen benign fibröz bir deri tümörüdür. Çeşitli kutanöz bölgelerde bildirilmiş olmasına rağmen, erkek genital bölge yerleşimi daha önce tanımlanmamıştır. OLGU SUNUMU: Yirmi yedi yaşında erkek hasta, penis frenulumunda yavaş büyüyen ve ağrısız bir kitle ile başvurdu. Hastanın, cinsel uyarılma sırasında üretral akıntıyı önlemek amacıyla frenulum çevresine tekrarlayan şekilde bant uygulama öyküsü mevcuttu ve bu durum kronik mekanik iritasyona yol açmıştı. Lezyon spinal anestezi altında tamamen eksize edildi. Histopatolojik incelemede, nükleer atipi içermeyen pleomorfik fibroblast benzeri hücreler ve güçlü vimentin pozitifliği saptanarak pleomorfik fibrom tanısı doğrulandı. Altı aylık takipte nüks izlenmedi. TARTIŞMA: Pleomorfik fibrom, belirgin sitolojik pleomorfizme rağmen klinik olarak indolent seyirli nadir bir benign neoplazmdır. Genital tutulum son derece nadirdir ve sunulan olgu, penis yerleşimli ilk vaka niteliğindedir. Kronik mekanik mikrotravmanın fibroblastik proliferasyonu tetikleyerek patogenezde rol oynayabileceği düşünülmektedir. SONUÇ: Pleomorfik fibrom, özellikle kronik lokal travma öyküsü bulunan hastalarda penis kitlelerinin ayırıcı tanısında dikkate alınmalıdır. Cerrahi eksizyon küratif olup, nüks son derece nadirdir. Anahtar Kelimeler: pleomorfik fibroma, penis, benign tümör, kronik iritasyon
- 1 January 2026
- Published by Turk Androloji Dernegi in Androloji Bülteni
Pleomorphic fibroma of the penis: A rare case report
GİRİŞ: Pleomorfik fibrom, ilk kez 1989 yılında Kamino ve ark. tarafından tanımlanan, nadir görülen benign fibröz bir deri tümörüdür. Çeşitli kutanöz bölgelerde bildirilmiş olmasına rağmen, erkek genital bölge yerleşimi daha önce tanımlanmamıştır. OLGU SUNUMU: Yirmi yedi yaşında erkek hasta, penis frenulumunda yavaş büyüyen ve ağrısız bir kitle ile başvurdu. Hastanın, cinsel uyarılma sırasında üretral akıntıyı önlemek amacıyla frenulum çevresine tekrarlayan şekilde bant uygulama öyküsü mevcuttu ve bu durum kronik mekanik iritasyona yol açmıştı. Lezyon spinal anestezi altında tamamen eksize edildi. Histopatolojik incelemede, nükleer atipi içermeyen pleomorfik fibroblast benzeri hücreler ve güçlü vimentin pozitifliği saptanarak pleomorfik fibrom tanısı doğrulandı. Altı aylık takipte nüks izlenmedi. TARTIŞMA: Pleomorfik fibrom, belirgin sitolojik pleomorfizme rağmen klinik olarak indolent seyirli nadir bir benign neoplazmdır. Genital tutulum son derece nadirdir ve sunulan olgu, penis yerleşimli ilk vaka niteliğindedir. Kronik mekanik mikrotravmanın fibroblastik proliferasyonu tetikleyerek patogenezde rol oynayabileceği düşünülmektedir. SONUÇ: Pleomorfik fibrom, özellikle kronik lokal travma öyküsü bulunan hastalarda penis kitlelerinin ayırıcı tanısında dikkate alınmalıdır. Cerrahi eksizyon küratif olup, nüks son derece nadirdir. Anahtar Kelimeler: pleomorfik fibroma, penis, benign tümör, kronik iritasyon
- 16 December 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 58 (6) , 2073-2079
Kidney stabilization in supine percutaneous nephrolithotomy: impact on surgical efficiency and stone-free rates
Kidney mobility during supine percutaneous nephrolithotomy (sPCNL) may negatively affect the accuracy of the approach and surgical efficacy. This study investigated the effects of kidney stabilization on surgical efficacy, stone-free rate (SFR), and complication profile. Eighty-five patients who underwent standard sPCNL for ≥ 2 cm kidney stones between January and August 2025 were retrospectively reviewed. Patients were divided into two groups: conventional sPCNL (Group C, n = 41) and sPCNL with external gel bag for kidney stabilization (Group F, n = 44). Demographic and stone characteristics, operative time, access time, fluoroscopy time, hemoglobin drop, transfusion rates, length of stay (LOS), complications, and SFR were compared. The groups were similar in terms of demographic and stone characteristics. In Group F, the operative time (74.7 ± 32.2 vs. 97.5 ± 38.0 min, p = 0.004), access time, and fluoroscopy time were significantly shorter (p < 0.001 for both). LOS was shorter in Group F (2.3 vs. 3.1 days, p = 0.001). Hemoglobin decline was less in Group F (1.20 ± 0.81 vs. 1.78 ± 1.31 g/dL, p = 0.017). Transfusion and major complication rates were similar. SFR was significantly higher in Group F (88.6% vs. 70.7%, p = 0.030). Multivariate analysis demonstrated that kidney stabilization was an independent predictor of achieving stone-free status (p = 0.032). Kidney stabilization reduces mobility during sPCNL, thereby shortening operative and fluoroscopy times, reducing blood loss, and improving SFR. These retrospective findings suggest that this simple technique may enhance surgical efficiency; however, its clinical value should be confirmed in prospective studies.
- 16 December 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 58 (6) , 2073-2079
Kidney stabilization in supine percutaneous nephrolithotomy: impact on surgical efficiency and stone-free rates
Kidney mobility during supine percutaneous nephrolithotomy (sPCNL) may negatively affect the accuracy of the approach and surgical efficacy. This study investigated the effects of kidney stabilization on surgical efficacy, stone-free rate (SFR), and complication profile. Eighty-five patients who underwent standard sPCNL for ≥ 2 cm kidney stones between January and August 2025 were retrospectively reviewed. Patients were divided into two groups: conventional sPCNL (Group C, n = 41) and sPCNL with external gel bag for kidney stabilization (Group F, n = 44). Demographic and stone characteristics, operative time, access time, fluoroscopy time, hemoglobin drop, transfusion rates, length of stay (LOS), complications, and SFR were compared. The groups were similar in terms of demographic and stone characteristics. In Group F, the operative time (74.7 ± 32.2 vs. 97.5 ± 38.0 min, p = 0.004), access time, and fluoroscopy time were significantly shorter (p < 0.001 for both). LOS was shorter in Group F (2.3 vs. 3.1 days, p = 0.001). Hemoglobin decline was less in Group F (1.20 ± 0.81 vs. 1.78 ± 1.31 g/dL, p = 0.017). Transfusion and major complication rates were similar. SFR was significantly higher in Group F (88.6% vs. 70.7%, p = 0.030). Multivariate analysis demonstrated that kidney stabilization was an independent predictor of achieving stone-free status (p = 0.032). Kidney stabilization reduces mobility during sPCNL, thereby shortening operative and fluoroscopy times, reducing blood loss, and improving SFR. These retrospective findings suggest that this simple technique may enhance surgical efficiency; however, its clinical value should be confirmed in prospective studies.
- 24 September 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 37 (10) , 843-849
Chatbots’ performance in premature ejaculation questions: a comparative analysis of reliability, readability, and understandability
This study aimed to evaluate the reliability, readability, and understandability of chatbot responses to frequently asked questions about premature ejaculation, and to assess the contributions, potential risks, and limitations of artificial intelligence. Fifteen questions were selected using data from Google Trends and posed to the chatbots Copilot, Gemini, ChatGPT4o, ChatGPT4oPlus, and DeepSeek-R1. Reliability was evaluated using the Global Quality Scale(GQS) by two experts, readability was assessed with the Flesch Kincaid Reading Ease(FKRE), Flesch Kincaid Grade Level(FKGL), Gunning Fog Index(GFI), and Simple Measure of Gobbledygook(SMOG), and understandability was evaluated using the Patient Educational Materials Assessment Tool for Printable Materials(PEMAT-P). Additionally, the consistency of source citations was examined. The GQS were as follows: Copilot: 3.96 ± 0.66, Gemini: 3.66 ± 0.78, ChatGPT4o: 4.83 ± 0.23, ChatGPT4oPlus: 4.83 ± 0.29, DeepSeek-R1:4.86 ± 0.22 (p < 0.001). The PEMAT-P were as follows: Copilot: 0.70 ± 0.05, Gemini: 0.72 ± 0.04, ChatGPT4o: 0.83 ± 0.03, ChatGPT4oPlus: 0.77 ± 0.06, DeepSeek-R1:0.79 ± 0.06 (p < 0.001). While ChatGPT4oPlus and DeepSeek-R1 scored higher for reliability and understandability, all chatbots performed at an acceptable level (≥70%). However, readability scores were above the recommended level for the target audience. Instances of low reliability or unverified sources were noted, with no significant differences between the chatbots. Chatbots provide highly reliable and informative responses regarding premature ejaculation; however, it is evident that there are significant limitations that require improvement, particularly concerning readability and the reliability of sources.
- 24 September 2025
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 37 (10) , 843-849
Chatbots’ performance in premature ejaculation questions: a comparative analysis of reliability, readability, and understandability
This study aimed to evaluate the reliability, readability, and understandability of chatbot responses to frequently asked questions about premature ejaculation, and to assess the contributions, potential risks, and limitations of artificial intelligence. Fifteen questions were selected using data from Google Trends and posed to the chatbots Copilot, Gemini, ChatGPT4o, ChatGPT4oPlus, and DeepSeek-R1. Reliability was evaluated using the Global Quality Scale(GQS) by two experts, readability was assessed with the Flesch Kincaid Reading Ease(FKRE), Flesch Kincaid Grade Level(FKGL), Gunning Fog Index(GFI), and Simple Measure of Gobbledygook(SMOG), and understandability was evaluated using the Patient Educational Materials Assessment Tool for Printable Materials(PEMAT-P). Additionally, the consistency of source citations was examined. The GQS were as follows: Copilot: 3.96 ± 0.66, Gemini: 3.66 ± 0.78, ChatGPT4o: 4.83 ± 0.23, ChatGPT4oPlus: 4.83 ± 0.29, DeepSeek-R1:4.86 ± 0.22 (p < 0.001). The PEMAT-P were as follows: Copilot: 0.70 ± 0.05, Gemini: 0.72 ± 0.04, ChatGPT4o: 0.83 ± 0.03, ChatGPT4oPlus: 0.77 ± 0.06, DeepSeek-R1:0.79 ± 0.06 (p < 0.001). While ChatGPT4oPlus and DeepSeek-R1 scored higher for reliability and understandability, all chatbots performed at an acceptable level (≥70%). However, readability scores were above the recommended level for the target audience. Instances of low reliability or unverified sources were noted, with no significant differences between the chatbots. Chatbots provide highly reliable and informative responses regarding premature ejaculation; however, it is evident that there are significant limitations that require improvement, particularly concerning readability and the reliability of sources.
- 27 August 2021
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 20 (3) , 189-191
Unique Approach to Paediatric Sertoliform Cystadenoma of the Rete Testis: A Case of Testis-Sparing Surgery
- 27 August 2021
- Published by Galenos Yayinevi in Üroonkoloji Bülteni
- Vol. 20 (3) , 189-191
Unique Approach to Paediatric Sertoliform Cystadenoma of the Rete Testis: A Case of Testis-Sparing Surgery